89 related articles for article (PubMed ID: 15046543)
21. Pharmacology of antidepressants: selectivity or multiplicity?
Westenberg HG
J Clin Psychiatry; 1999; 60 Suppl 17():4-8; discussion 46-8. PubMed ID: 10446734
[TBL] [Abstract][Full Text] [Related]
22. Serotonergic mechanisms and the new antidepressants.
Stahl SM
Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
[No Abstract] [Full Text] [Related]
23. Can recovery from depression be achieved?
Shelton RC; Tomarken AJ
Psychiatr Serv; 2001 Nov; 52(11):1469-78. PubMed ID: 11684742
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological principles of antidepressant efficacy.
Schatzberg AF
Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
[TBL] [Abstract][Full Text] [Related]
25. Considerations in choosing an antidepressant.
Kingsbury SJ; Simpson GM
Psychiatr Serv; 2001 Nov; 52(11):1435-6. PubMed ID: 11684736
[No Abstract] [Full Text] [Related]
26. Differences in mechanism of action between current and future antidepressants.
Stahl SM; Grady MM
J Clin Psychiatry; 2003; 64 Suppl 13():13-7. PubMed ID: 14552651
[TBL] [Abstract][Full Text] [Related]
27. Monoamine dysfunction and the pathophysiology and treatment of depression.
Charney DS
J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
[TBL] [Abstract][Full Text] [Related]
28. Selectivity of antidepressants: from the monoamine hypothesis of depression to the SSRI revolution and beyond.
Owens MJ
J Clin Psychiatry; 2004; 65 Suppl 4():5-10. PubMed ID: 15046536
[TBL] [Abstract][Full Text] [Related]
29. Physical symptoms comorbid with depression and the new antidepressant duloxetine.
Bailey KP
J Psychosoc Nurs Ment Health Serv; 2003 Dec; 41(12):13-8. PubMed ID: 14682027
[TBL] [Abstract][Full Text] [Related]
30. [Enantiomers: a new problem in pharmacotherapy of depression?].
Grodner B; Sitkiewicz D
Psychiatr Pol; 2013; 47(3):511-8. PubMed ID: 23885544
[TBL] [Abstract][Full Text] [Related]
31. Antidepressants.
Frazer A
J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
[No Abstract] [Full Text] [Related]
32. The dual-action hypothesis: does pharmacology matter?
Shelton RC
J Clin Psychiatry; 2004; 65 Suppl 17():5-10. PubMed ID: 15600376
[TBL] [Abstract][Full Text] [Related]
33. Possible neurobiological mechanisms underlying faster onset of antidepressant action.
Blier P
J Clin Psychiatry; 2001; 62 Suppl 4():7-11; discussion 37-40. PubMed ID: 11229789
[TBL] [Abstract][Full Text] [Related]
34. Augmentation strategies with serotonergic-noradrenergic combinations.
Nelson JC
J Clin Psychiatry; 1998; 59 Suppl 5():65-8; discussion 69. PubMed ID: 9635550
[TBL] [Abstract][Full Text] [Related]
35. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
Blier P; de Montigny C
Biol Psychiatry; 1998 Sep; 44(5):313-23. PubMed ID: 9755353
[TBL] [Abstract][Full Text] [Related]
36. Role of norepinephrine in depression.
Delgado PL; Moreno FA
J Clin Psychiatry; 2000; 61 Suppl 1():5-12. PubMed ID: 10703757
[TBL] [Abstract][Full Text] [Related]
37. [Clomipramine and other serotonin reuptake inhibitors in the treatment of depressed mood, anxiety and impaired impulse control].
Eriksson E
Psychiatr Pol; 1994; 28(5):601-12. PubMed ID: 7991713
[TBL] [Abstract][Full Text] [Related]
38. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
Trivedi MH; Hollander E; Nutt D; Blier P
J Clin Psychiatry; 2008 Feb; 69(2):246-58. PubMed ID: 18363453
[TBL] [Abstract][Full Text] [Related]
39. Second messengers.
Keltner NL; Gorman AG
Perspect Psychiatr Care; 2007 Feb; 43(1):60-4. PubMed ID: 17295861
[No Abstract] [Full Text] [Related]
40. Serotonin dysfunction disorders: a behavioral neurochemistry perspective.
Petty F; Davis LL; Kabel D; Kramer GL
J Clin Psychiatry; 1996; 57 Suppl 8():11-6. PubMed ID: 8698675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
